Sagimet Biosciences Inc.

Ownership Transactions Reported by 23 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+14.3K	20.1%	$5.02	+$71.7K
Sells	3	-57K	79.9%	$3.13	-$178K
Net	-2	-42.7K	-59.9%		-$106K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
New Enterprise Associates 13 Lp	10%+ Owner	$12.3M			Jan 29, 2024
NEA Partners 13, Limited Partnership	10%+ Owner	$12.3M			Jan 29, 2024
Beth C. Seidenberg	Director	$8.33M			Jun 5, 2024
KPCB PBD Associates, LLC	10%+ Owner	$7.79M			Jul 18, 2023
Jinzi Jason Wu	Director	$6.78M			Jul 18, 2023
David Happel	President & CEO, Director	$3.37M	+$71.7K	+2.18%	Mar 26, 2024
Elizabeth Rozek	General Counsel and CCO	$1.2M	-$33.8K	-2.74%	Jul 19, 2024
George Kemble	Executive Chairman, Director	$1.02M	-$118K	-10.4%	Jul 23, 2024
Eduardo Bruno Martins	Chief Medical Officer	$619K	-$25.9K	-4.02%	Jul 19, 2024
Patrick J. Kerins	10%+ Owner	$53.9K			Jan 29, 2024
Merdad Parsey	Director	$52.5K			Jun 5, 2024
Forest Baskett	10%+ Owner	$46.3K			Jan 29, 2024
Scott D. Sandell	10%+ Owner	$28.7K			Jan 29, 2024
Timothy P. Walbert	Director	$9.02K			Jun 5, 2024
Dennis Hom	Chief Financial Officer				Jul 18, 2023
Jennifer Jarrett	Director				Aug 1, 2024
Anne M. Phillips	Director				Aug 1, 2024
Richard J. Rodgers	Director				Jul 18, 2023
Thierry Chauche	Chief Financial Officer				May 6, 2024
Anthony M. Rimac	Chief Operating Officer				Jul 18, 2023
Joseph Oriti	Officer Title: Interim Principal Financial Officer. Exhibit 24 - Power of Attorney				Feb 1, 2024
Paul W. Hoelscher	Director				Jun 5, 2024
Elizabeth Grammer	Director				Jun 5, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.